FOLFIRINOX versus gemcitabine-based therapy for pancreatic ductal adenocarcinoma: Lessons from patient-derived cell lines

Sebastian K.S. Begg, David J. Birnbaum, Jeffrey W. Clark, Mari Mino-Kenudson, Ulrich F. Wellner, Oliver Schilling, Keith D. Lillemoe, Andrew L. Warshaw, Carlos Fernández Del Castillo, Andrew S. Liss^*

^*Korrespondierende/r Autor/-in für diese Arbeit